Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study Evaluating the Proper Surgical Safety Margin for Early Stage Oral Tongue Cancers: A Prospective Multicenter Randomized Non-inferiority Clinical Trial

NCT04738786 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT04738786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04738786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study Evaluating the Proper Surgical Safety Margin for Early Stage Oral Tongue Cancers: A Prospective Multicenter Randomized Non-inferiority Clinical Trial
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Terminated
Start date
January 18, 2021
Completion date
January 31, 2025
Enrollment
125 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

resection margin, squamous cell carcinoma, surgery, tongue cancer, tongue cancer tnm staging primary tumor (t) t1, tongue cancer tnm staging primary tumor (t) t2